- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
- Locations
-
- Peking Union Medical College Hospital Beijing, China
Clinical trial condition
Intrahepatic Cholangiocarcinoma (Icc)
Explore clinical trials studying Intrahepatic Cholangiocarcinoma (Icc). Study availability and eligibility vary by location and protocol.
33 public trials
17 recruiting studies
Intrahepatic Cholangiocarcinoma (Icc) trial results
NCT07063888
- Conditions
- Adenocarcinoma, Adjuvant Chemoradiotherapy, Carcinoma, +8 more
- Locations
-
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, China
NCT06888063
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +8 more
- Locations
-
- Erasmus Medical Center Rotterdam, South Holland, Netherlands
NCT06862934
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +5 more
- Locations
-
- Fondazione IRCCS Istituto Nazionale Tumori di Milano Milan, Italy
NCT06852287
- Conditions
- Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +13 more
- Locations
-
- Tianjin Medical University Cancer Institute and Hospital Tianjin, Tia, China
NCT06721286
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +5 more
- Locations
-
- Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China
NCT05678270
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
- Locations
-
- Anhui Provincial Hospital Hefei, Anhui, China
- Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
- Beijing Youan Hosptital,Capital Medical University Beijing, Beijing Municipality, China
Not Yet Recruiting
Intraarterial Therapies Plus Tislelizumab Plus Lenvatinib Versus Tislelizumab Plus Gemcitabine-Cisplatin in Unresectable Intrahepatic Cholangiocarcinoma
NCT07691515
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +5 more
- Locations
-
- The First Affiliated Hospital, Sun Yat-sen University Guangzhou, Guangdong, China
- Jinshazhou Hospital of Guangzhou University of Chinese Medicine Guangzhou, Guangdong, China
- Guangdong Second People's Hospital Guangzhou, Guangdong, China
- The Affiliated Panyu Central Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
Not Yet Recruiting
FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma
NCT07353827
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +6 more
- Locations
-
- Sun Yat-san University Cancer Center Guangzhou, Guangdong, China
NCT07328919
- Conditions
- Adenocarcinoma, Advanced Cholangiocarcinoma, Carcinoma, +6 more
- Locations
-
- Anhui Provincial Hospital Hefei, Anhui, China
- Fujian Cancer Hospital Fuzhou, Fujian, China
- Zhujiang Hospital of Southern Medical University Guangzhou, Guangdong, China
- The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China